Zobrazeno 1 - 10
of 137
pro vyhledávání: '"Geoffrey B, Johnson"'
Autor:
Mohamed E. Ahmed, Ahmed M. Mahmoud, Guiseppe Reitano, Wael Zeina, Kelly Lehner, Carter A. Day, Irbaz Riaz, Daniel S. Childs, Jacob J. Orme, A. Tuba Kendi, Geoffrey B. Johnson, R. Jeffrey Karnes, Eugene D. Kwon, Jack R. Andrews
Publikováno v:
European Urology Open Science, Vol 66, Iss , Pp 38-45 (2024)
Background and objective: Visceral metastatic disease in prostate cancer patients conveys a poor prognosis. Using advanced imaging techniques, studies have demonstrated increasing detection rates of visceral metastasis. Visceral metastases are now se
Externí odkaz:
https://doaj.org/article/8d4eb652bd404f21a76df8cc20d2d208
Autor:
Gokce Belge Bilgin, Cem Bilgin, Daniel S. Childs, Jacob J. Orme, Brian J. Burkett, Ann T. Packard, Derek R. Johnson, Matthew P. Thorpe, Irbaz Bin Riaz, Thorvardur R. Halfdanarson, Geoffrey B. Johnson, Oliver Sartor, Ayse Tuba Kendi
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundMany patients use artificial intelligence (AI) chatbots as a rapid source of health information. This raises important questions about the reliability and effectiveness of AI chatbots in delivering accurate and understandable information.Pu
Externí odkaz:
https://doaj.org/article/7ca738fae743479887d0e6ee453667e6
Autor:
Ahmed M. Mahmoud, Mohamed E. Ahmed, A. Tuba Kendi, Matthew Thorpe, Geoffrey B. Johnson, Irbaz Bin Riaz, Jacob J. Orme, Eugene D. Kwon, Jack R. Andrews, Daniel S. Childs
Publikováno v:
BJUI Compass, Vol 5, Iss 2, Pp 319-324 (2024)
Abstract Background For men with prostate cancer, radiographic progression may occur without a concordant rise in prostate‐specific antigen (PSA). Our study aimed to assess the prevalence of radiographic progression using C‐11 choline positron em
Externí odkaz:
https://doaj.org/article/29b24f73a0de43fead3611b2e5a728e1
Autor:
Scott M. Thompson, Garima Suman, Michael S. Torbenson, Zong‐Ming E. Chen, Danielle E. Jondal, Anurima Patra, Eric C. Ehman, James C. Andrews, Chad J. Fleming, Brian T. Welch, Anil N. Kurup, Lewis R. Roberts, Kymberly D. Watt, Mark J. Truty, Sean P. Cleary, Rory L. Smoot, Julie K. Heimbach, Nguyen H. Tran, Amit Mahipal, Jun Yin, Tyler Zemla, Chen Wang, Zachary Fogarty, Mark Jacobson, Bradley J. Kemp, Sudhakar K. Venkatesh, Geoffrey B. Johnson, David A. Woodrum, Ajit H. Goenka
Publikováno v:
Hepatology Communications, Vol 6, Iss 5, Pp 1172-1185 (2022)
Prostate‐specific membrane antigen (PSMA) is a validated target for molecular diagnostics and targeted radionuclide therapy. Our purpose was to evaluate PSMA expression in hepatocellular carcinoma (HCC), cholangiocarcinoma (CCA), and hepatic adenom
Externí odkaz:
https://doaj.org/article/b42faebfcfd446968d3296f78342143e
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 14, p 11626 (2023)
Radiopharmaceuticals are rapidly developing as a field, with the successful use of targeted beta emitters in neuroendocrine tumors and prostate cancer serving as catalysts. Targeted alpha emitters are in current development for several potential onco
Externí odkaz:
https://doaj.org/article/e446452a1e7a48e59337b40c2558ef49
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Somatostatin receptor 2 (SSTR2) has been shown to be expressed in a subset of neuroendocrine tumors and carcinomas and plays a role in imaging studies and guiding therapy. Patients with tumors expressing SSTR2 may be successfully treated with somatos
Externí odkaz:
https://doaj.org/article/3023d84453c3465fbb3832a9da910e73
Autor:
Sujata Saha, Robert A. Vierkant, Geoffrey B. Johnson, Ahmad Parvinian, Robert A. Wermers, Trenton Foster, Travis McKenzie, Benzon Dy, Melanie Lyden
Publikováno v:
Surgery. 173:117-123
Autor:
Sean S. Park, Haidong Dong, Eugene D. Kwon, Thomas M. Pisansky, Kenneth R. Olivier, Mark A. Nathan, Geoffrey B. Johnson, Brian A. Costello, William S. Harmsen, J. Fernando Quevedo, Brian J. Davis, Matthew J. Iott, Debra H. Brinkmann, C. Richard Choo, Lance C. Pagliaro, Michael S. Bold, Erik J. Tryggestad, Fabrice Lucien, Val J. Lowe, B.J. Stish, Feven Abraha, Jacob J. Orme, Henan Zhang
Supplementary Table 1. PSA progression by number of sites treated. 1Kaplan-Meier method; 2Cox model; 3Logrank test; 4Wald Chi-Square test.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::435496c52206d4162494014aa5efdeaa
https://doi.org/10.1158/1078-0432.22484216
https://doi.org/10.1158/1078-0432.22484216
Autor:
Sean S. Park, Haidong Dong, Eugene D. Kwon, Thomas M. Pisansky, Kenneth R. Olivier, Mark A. Nathan, Geoffrey B. Johnson, Brian A. Costello, William S. Harmsen, J. Fernando Quevedo, Brian J. Davis, Matthew J. Iott, Debra H. Brinkmann, C. Richard Choo, Lance C. Pagliaro, Michael S. Bold, Erik J. Tryggestad, Fabrice Lucien, Val J. Lowe, B.J. Stish, Feven Abraha, Jacob J. Orme, Henan Zhang
Supplementary Figure 2. Flow cytometry gating strategies. (A) Flow cytometry gating strategies of central memory (TCM), effector memory (TEM), effector (TEF), and naïve (TN) T-cells populations. (B) Flow cytometry gating strategies of tumor reactive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69aab2adb4778ae7d147b8f04e57e5df
https://doi.org/10.1158/1078-0432.22484222.v1
https://doi.org/10.1158/1078-0432.22484222.v1
Autor:
Sean S. Park, Haidong Dong, Eugene D. Kwon, Thomas M. Pisansky, Kenneth R. Olivier, Mark A. Nathan, Geoffrey B. Johnson, Brian A. Costello, William S. Harmsen, J. Fernando Quevedo, Brian J. Davis, Matthew J. Iott, Debra H. Brinkmann, C. Richard Choo, Lance C. Pagliaro, Michael S. Bold, Erik J. Tryggestad, Fabrice Lucien, Val J. Lowe, B.J. Stish, Feven Abraha, Jacob J. Orme, Henan Zhang
Supplementary Figure 1. PSA and distant progression by number of radiation-treated sites. (A) PSA progression by number of sites treated. (B) Distant radiographic progression by number of sites treated.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e12a24bdfd2a5cc529eca9b68e0d60b0
https://doi.org/10.1158/1078-0432.22484225.v1
https://doi.org/10.1158/1078-0432.22484225.v1